Navigation Links
LTCPA Study Quantifying Unused Medicare Part D Drugs in Skilled Nursing Facilities Published in The Consultant Pharmacist

WASHINGTON, Sept. 7, 2011 /PRNewswire-USNewswire/ -- The Long Term Care Pharmacy Alliance's (LTCPA) recent study, "Measurement of Unused Medication in Medicare D Residents in Skilled Nursing Facilities," has been published in the September 2011 issue of The Consultant Pharmacist, the official peer-reviewed journal of the American Society of Consultant Pharmacists. This is the first published, peer-reviewed study to measure the quantity and the value of unused solid oral dosage from prescription drugs among Medicare Part D–covered residents in skilled nursing facilities.  The study was based upon actual dispensed and returned prescription data provided to the authors by long-term care pharmacies, and its data and methodology have undergone a rigorous peer-review.  

The study highlights several important findings:

  • The cost of unused Part D drug products dispensed to skilled nursing facility residents that could feasibly be reduced to shorter fill times – identified as brand and generic oral solid prescriptions – amounts to about 2.9% of total dispensed value of all prescriptions, or $125 million annually.
  • Based on the value of the unused drugs, moving to shorter fills via "short cycle dispensing" will very likely result in higher costs to the Medicare program. Shorter fills will result in more dispensed prescriptions and more dispensing fees charged to Medicare Part D prescription plans, overwhelming any potential savings.

The study, conducted by Managed Solutions, LLC and originally released by LTCPA in January 2011, supports pharmacists' contention that the "short cycle dispensing" provision inserted within the Patient Protection and Affordable Care Act (PPACA) is likely to create greater health care costs rather than savings. The intent of the provision was to reduce costs associated with medications unused by Part D-covered skilled nursing facility residents by moving from traditional 30-day fills to shorter fill times such as biweekly, weekly or daily. Debate has circulated around this provision and subsequent rule-making, as robust data quantifying the amount and costs associated with unused pharmaceuticals in the long term care space were not available. The study fills this gap in data and demonstrates that the costs associated with increasing the number of monthly dispensings are likely to outweigh any cost savings from reducing unused drugs.

To read the published study, click here.

The Long Term Care Pharmacy Alliance (LTCPA) advocates for the interests of the long term care (LTC) pharmacy community - a community that provides a critical component to the daily care of individuals living in LTC settings. LTCPA provides a national, unified voice on major issues including LTC pharmacy costs, specialized nursing facility pharmacy services and the Medicare Part D prescription drug benefit.  LTCPA membership is comprised of three national LTC pharmacy providers, Managed Health Care Associates (MHA), Omnicare and PharMerica that together serve 1.8 million Medicare Part D beneficiaries, or ninety percent of all LTC facility residents.

SOURCE Long Term Care Pharmacy Alliance (LTCPA)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Long Term Care Pharmacy Alliance Concerned with Proposed CMS Rule; New Study Confirms LTCPA Position
2. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
3. Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX® Multi-Cord Study
4. NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
5. Study Uncovers Key Success Factors and Common Failure Points for Launching New Metabolic Products in Todays Competitive Healthcare Market
6. Study Explores Utilization Trends for Prostate Cancer Treatments
7. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
8. Kuros Completes Patient Recruitment in its European Clinical Study With KUR-023, its Novel Dural Sealant Product Candidate
9. New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses
10. Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
11. Comparative Study Confirms Enox Biopharmas Antimicrobial Superiority to Commercially Available Silver Coated Catheters
Post Your Comments:
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017  PMD ... OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... strategic hub service that expedites and streamlines patient and ... Spiro PD 2.0, and wellness management services.  ... medical device used to measure lung function for a ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September ... Washington, D.C. offering free MRI brain scans to the public.Where:  ... will be parked at 501 K Street NW, Washington, D.C.What:BTF brings its ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
Breaking Medicine News(10 mins):